From February 26, 2024 to March 26, 2024, the company has repurchased 210,800 shares, representing 6.33% for ¥189.93 million. With this, the company has completed the repurchase of 210,800 shares, representing 6.33% for ¥189.93 million under the buyback announced on February 26, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,007 JPY | -0.59% | -8.12% | +0.60% |
1st Jan change | Capi. | |
---|---|---|
+0.60% | 21.73M | |
-5.95% | 9.25B | |
+32.54% | 1.32B | |
-7.72% | 361M | |
+0.79% | 269M | |
+12.22% | 231M | |
-39.22% | 93.72M | |
-9.17% | 86.88M | |
+19.44% | 59.62M |
- Stock Market
- Equities
- 9776 Stock
- News Sapporo Clinical Laboratory Inc.
- Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on February 26, 2024.